Predictors of Death after Clostridium difficile Infection: A Report on 128 Strain-Typed Cases from a Teaching Hospital in the United Kingdom

Clinical Infectious Diseases

Volumn 50, Issue 12, 2010, Pages

  Wilson, Vhairi ^a   Cheek, Liz ^b   Satta, Giovanni ^a   Walker Bone, Karen ^c   Cubbon, Marc ^a   Citron, Diane ^d   Gerding, Dale N ^e,f   Llewelyn, Martin J ^a,c  

^a NATIONAL HEALTH SERVICE   (United Kingdom)

^b UNIVERSITY OF BRIGHTON   (United Kingdom)

^c BRIGHTON AND SUSSEX MEDICAL SCHOOL   (United Kingdom)

^d RM Alden Laboratory ^*  (United States)

^e HINES VA HOSPITAL   (United States)

^f LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; CLOSTRIDIUM DIFFICILE TOXIN A; CLOSTRIDIUM DIFFICILE TOXIN B; CREATININE; METRONIDAZOLE; UREA; VANCOMYCIN;

ABDOMINAL DISTENSION; ABDOMINAL PAIN; ABDOMINAL TENDERNESS; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; ASCITES; BACTERIAL STRAIN; BACTERIUM ISOLATE; BLOODY DIARRHEA; CARDIOVASCULAR SYMPTOM; CEREBROVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ASSESSMENT; CLINICAL FEATURE; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; COMORBIDITY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEHYDRATION; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; FECES ANALYSIS; FEMALE; FEVER; HUMAN; HYPOALBUMINEMIA; ILEUS; IMMUNOCOMPROMISED PATIENT; ISCHEMIC HEART DISEASE; KIDNEY FAILURE; LEUKOCYTE COUNT; LIQUID FECES; MAJOR CLINICAL STUDY; MALE; MENTAL DEFICIENCY; MORTALITY; NEOPLASM; NONHUMAN; OUTCOME ASSESSMENT; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENT DISEASE; RESTRICTION MAPPING; SURVIVAL; TEACHING HOSPITAL; TOXIC MEGACOLON; TREATMENT FAILURE; UNITED KINGDOM; UREA BLOOD LEVEL;

AGED; AGED, 80 AND OVER; ANTI-INFECTIVE AGENTS; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; FECES; FEMALE; GREAT BRITAIN; HOSPITALS, TEACHING; HUMANS; MALE; METRONIDAZOLE; PROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 77953002541     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/653012     Document Type: Article

References (13)

1. Loo VG, Poirier L, Miller MA, et al. A predominantly clonal multiinstitutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 2005; 353: 2442-2449.
2. McDonald LC, Killgore GE, Thompson A, et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med 2005; 353: 2433-2441.
3. Morgan OW, Rodrigues B, Elston T, et al. Clinical severity of Clostridium difficile PCR ribotype 027: a case-case study. PLoS ONE 2008; 3: e1812.
4. Cloud J, Noddin L, Pressman A, Hu M, Kelly C. Clostridium difficile strain NAP-1 is not associated with severe disease in a nonepidemic setting. Clin Gastroenterol Hepatol 2009; 7: 868-873.
5. Health Protection Agency. Results of the mandatory Clostridium difficile reporting scheme. http://www.hpa.org.uk/Topics/InfectiousDiseases/InfectionsAZ/ ClostridiumDifficile/EpidemiologicalData/Mandatory Surveillance/ cdiffMandatoryReportingScheme. Updated 10 March 2010. Accessed 29 April 2009.
6. Killgore G, Thompson A, Johnson S, et al. Comparison of seven techniques for typing international epidemic strains of Clostridium difficile: restriction endonuclease analysis, pulsed-field gel electrophoresis, PCR-ribotyping, multilocus sequence typing, multilocus variable-number tandem-repeat analysis, amplified fragment length polymorphism, and surface layer protein a gene sequence typing. J Clin Microbiol 2008; 46: 431-437.
7. Razavi B, Apisarnthanarak A, Mundy LM. Clostridium difficile: emergence of hypervirulence and fluoroquinolone resistance. Infection 2007; 35: 300-307.
8. Brazier JS, Raybould R, Patel B, et al. Distribution and antimicrobial susceptibility patterns of Clostridium difficile PCR ribotypes in English hospitals, 2007-2008. Euro Surveill 2008; 13(41): 988:19000.
9. Bishara J, Peled N, Pitlik S, Samra Z. Mortality of patients with antibiotic-associated diarrhoea: the impact of Clostridium difficile. J Hosp Infect 2008; 68: 308-314.
10. Drew RJ, Boyle B. RUWA scoring system: a novel predictive tool for the identification of patients at high risk for complications from Clostridium difficile infection. J Hosp Infect 2009; 71: 93-94.
11. Belmares J, Gerding DN, Parada JP, Miskevics S, Weaver F, Johnson S. Outcome of metronidazole therapy for Clostridium difficile disease and correlation with a scoring system. J Infect 2007; 55: 495-501.
12. Zar FA, Bakkanagari SR, Moorthi KM, Davis MB. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. Clin Infect Dis 2007; 45: 302-307.
13. Mutlu E, Wroe AJ, Sanchez-Hurtado K, Brazier JS, Poxton IR. Molecular characterization and antimicrobial susceptibility patterns of Clostridium difficile strains isolated from hospitals in south-east Scotland. J Med Microbiol 2007; 56: 921-929.